Skip Navigation


European Heart Journal Advance Access originally published online on December 21, 2006
European Heart Journal 2007 28(2):143-145; doi:10.1093/eurheartj/ehl434
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/2/143    most recent
ehl434v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ng Kam Chuen, M. J.
Right arrow Articles by MacFadyen, R. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ng Kam Chuen, M. J.
Right arrow Articles by MacFadyen, R. J
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Variable aetiologies contributing to the anaemia of systolic heart failure are important to individual patient management

Marie Jennyfer Ng Kam Chuen1 and Robert J MacFadyen1,2,*

1 University Department of Medicine, Sandwell and West Birmingham NHS Trust, City Hospital, Dudley Road, Birmingham B18 7QH, UK
2 Department of Cardiology, Sandwell and West Birmingham NHS Trust, City Hospital, Dudley Road, Birmingham B18 7QH, UK

* Corresponding author. Tel: +44 121 507 4476 5080; fax: +44 121 554 4854. E-mail address: robert.macfadyen@swbh.nhs.uk

This editorial refers to ‘Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well’{dagger} by B.D. Westenbrink et al., on page 166

The first 10% of the full text of this article appears below.

The anaemia of chronic left ventricular systolic dysfunction (LVSD) or systolic heart failure is common, increases over time,1 and is linked with a bad clinical outcome. It is often considered an expression of the chronic vascular inflammation of endstage disease similar to that seen in conjunction with many other chronic disease states. Failure of haematinic function, particularly renal erythropoietin (Epo) synthesis and release, is also seen as a key mechanism and is cited as a major justification for considering exogenous Epo therapy in this disease. Westenbrink et al.2 from Groningen contribute a simple but critical clinical paper highlighting that variable mechanisms contribute to this clinical setting. By defining these carefully, Westenbrink shows that notwithstanding the impact of altered Epo kinetics and dynamics, many of these patients might also have ‘simple’ dilutional anaemia related to poorly perceived and asymptomatic fluid imbalance. This simple . . . [Full Text of this Article]

Haematological aspects of anaemia in LVSD

Epo kinetics as the dominant mechanism for anaemia in LVSD?

Where does fluid balance and renal resistance to diuresis fit in?

The importance of determining volume status in LVSD anaemia and in LVSD in general

Coordinated therapy for advanced anaemic LVSD


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well
B. Daan Westenbrink, Folkert W. Visser, Adriaan A. Voors, Tom D.J. Smilde, Erik Lipsic, Gerjan Navis, Hans L. Hillege, Wiek H. van Gilst, and Dirk J. van Veldhuisen
EHJ 2007 28: 166-171. [Abstract] [Full Text]